Page last updated: 2024-12-11

13-hydroperoxylinoleic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

## 13-Hydroperoxylinoleic acid (13-HPODE)

**What it is:**

13-Hydroperoxylinoleic acid (13-HPODE) is a **lipid peroxide** formed when linoleic acid, an omega-6 fatty acid, is oxidized by reactive oxygen species (ROS). It is one of the primary products of **lipid peroxidation** in cells.

**Why it's important for research:**

13-HPODE is a key player in various biological processes, making it a significant focus in research. Here are some key reasons:

**1. Role in Inflammation and Disease:**

* **Inflammation:** 13-HPODE is a potent inflammatory mediator. It activates signaling pathways, including the NF-κB pathway, leading to the production of pro-inflammatory cytokines like TNF-α and IL-6. This contributes to the development of chronic inflammatory diseases like arthritis, atherosclerosis, and inflammatory bowel disease.
* **Disease progression:** It can also contribute to the development of cancer by promoting cell proliferation and angiogenesis. Its involvement in oxidative stress, which damages DNA and leads to mutations, also makes it a potential factor in cancer progression.

**2. Biomarker for Oxidative Stress:**

* **Assessing oxidative damage:** Measuring levels of 13-HPODE can serve as an indicator of oxidative stress in tissues and cells. This information can be valuable in understanding the pathogenesis of various diseases associated with oxidative stress, like Alzheimer's disease, Parkinson's disease, and cardiovascular diseases.
* **Monitoring treatment efficacy:** Tracking 13-HPODE levels can help assess the effectiveness of treatments aimed at reducing oxidative stress.

**3. Potential Therapeutic Target:**

* **Anti-inflammatory agents:** The pro-inflammatory properties of 13-HPODE make it an attractive target for the development of novel anti-inflammatory drugs.
* **Cancer prevention:** Understanding how 13-HPODE contributes to cancer development could lead to new preventative strategies and therapeutic approaches.

**4. Insights into Lipid Metabolism:**

* **Lipid peroxidation pathway:** Studying 13-HPODE provides valuable insights into the mechanisms of lipid peroxidation and its role in cell signaling and homeostasis.
* **Dietary interventions:** Understanding how dietary factors influence the production of 13-HPODE can inform strategies for preventing chronic diseases through dietary modification.

**Overall, 13-HPODE plays a crucial role in various biological processes, making it a significant focus of research. Further investigations into its functions and interactions could lead to important discoveries in the development of new treatments and preventative strategies for a range of diseases.**

13-hydroperoxylinoleic acid: inhibits glyoxalase II; RN given refers to (?,Z)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID92035703
MeSH IDM0102331

Synonyms (4)

Synonym
13-hydroperoxylinoleic acid
Q27121901
DTXSID001229809
9,12-octadecadienoic acid, 13-hydroperoxy-, (?,z)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hydroperoxy polyunsaturated fatty acidAny polyunsaturated fatty acid carrying one or more hydroperoxy substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (44.83)18.7374
1990's10 (34.48)18.2507
2000's2 (6.90)29.6817
2010's4 (13.79)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]